WO2004000337A1 - Allomone repulsive and kairomone attractive compositions for controlling arachnids - Google Patents
Allomone repulsive and kairomone attractive compositions for controlling arachnids Download PDFInfo
- Publication number
- WO2004000337A1 WO2004000337A1 PCT/EP2003/007143 EP0307143W WO2004000337A1 WO 2004000337 A1 WO2004000337 A1 WO 2004000337A1 EP 0307143 W EP0307143 W EP 0307143W WO 2004000337 A1 WO2004000337 A1 WO 2004000337A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- derivatives
- isomers
- adipate
- trimethyl
- bis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N27/00—Biocides, pest repellants or attractants, or plant growth regulators containing hydrocarbons
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
- A01N37/04—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof polybasic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/06—Unsaturated carboxylic acids or thio analogues thereof; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/14—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/10—Animals; Substances produced thereby or obtained therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
Definitions
- the present invention relates to compositions of allomones and kairomones derived from the uropygial gland of ducks and chickens to treat Arachnida.
- Arachnida are a class of arthropods allied to insects and crustaceans, but having eight legs, no wings or antennae, two body regions and a breathing mechanism of a tracheal tube or a pulmonary source. Included in the class of arachnids are spiders, mites, ticks, daddy long legs and scorpions.
- the black widow spider is venomous and is fifteen times as toxic as the venom of the prairie rattlesnake.
- the black widow spider has no particular host preferences and therefore will bite any subject.
- the venom from a bite of a black widow spider is not mortal, there still exists some cases in which mortality has occurred in young or very old individuals.
- mice and deer are the most commonly infected animals which serve as hosts to ticks.
- ticks are the cause of Lyme disease which causes an acute inflammatory disease characterized by skin changes, joint inflammation and flu-like symptoms caused by the bacterium Borrelia burgdorferi transmitted by the bite of a deer tick.
- Lyme disease has been linked to a chronic syndrome of diffuse aches, pains, memory trouble and various other medical problems that can occur over months and even years in humans.
- the number of cases of Lyme disease has risen over the last few years and in the United States alone, a record high of 17,730 cases were reported in the year 2000.
- mites are parasitic and host specific. Certain mites migrate from birds, rodents, food material, vegetable matter and house dust and can attack and annoy humans.
- mites There are different categories of mites including Northern fowl mites (Ornithonyssus sylviarum), chicken mites (Dermanyssus gallinae), tropical rat mites (Ornithonyssus bacoti), house mouse mites (Liponyssoides san ⁇ ineus), follicle mites(Demo /e folliculorum), itch or scabies mites (Sarcoptes scabiei hominis), straw itch mites (Pyemotes tritici), grain (Acarus siro L.) and mold mites ( Tyrophagus putrescentiae) and house dust mites (Dermatophagoides sp.).
- Mites also infect a variety of other animals. The adults can be found in a variety of locations, while the eggs are usually deposited on the soil surface, in cracks and crevices and in some instances under the skin of the host they infest. Burrowing mange mites ( Sarcoptes scabiei) , as well as non-burrowing mange mites (Chorioptes bovis) are known to infest many animals including man. Feline mange mites (Notoedres cati), though fairly rare are highly contagious and infect kittens, cats and rabbits. Psoroptes ovis is the mite that infects sheep. Psoroptes bovis is the mite that infects cattle and Psoroptes cuniculi is the mite that infects rabbits. The Psoroptes group of mites causes scabies in the animals infected.
- Mites are parasitic and can feed on their host sucking their blood and causing anemia, itching, dermatitis and scabies. Their parasitic nature causes certain mites to be a menace, not only for humans, but especially for certain industries such as the poultry industry.
- Northern Fowl mites (Ornithonyssus sylviarum) is an external parasite of poultry with heavy populations capable of reducing egg production up to 10% to 15 %.
- the entire life cycle can be completed on a bird and consists of egg, larva, nymphal stages and adult.
- the eight legged adult is about 1/26 inch long and is dark red to black in color.
- the entire life cycle can be completed within one week.
- the chicken mite (Dermanyssus gallinae) sucks blood from poultry during the night and remains secluded during the day. These mites are generally gray in color and turn red after feeding. These mites can be barely seen without a magnifying glass.
- weight gains in various poultry is reduced, as well as egg production. In some instances with a large infestation of mites young birds and setting hens may actually die from mite-induced anemia.
- Mite infestation in poultry farming is a serious problem and results in not only loss of egg production, but also loss of the broiler chickens themselves.
- the poultry industry presently finds themselves loosing vast amounts of money due to the infestation of mites.
- the silica powder treatment can be done in the presence of the poultry, but requires a very strong dosage and one is obliged to saturate the silica powder throughout the poultry houses. Moreover, silica powder is known to cause a number of lung diseases both in birds and in man.
- One of the most prominent problems with chemical and silica powder treatment is that mites are known to inhabit in cracks and crevices of the poultry houses and hence are difficult to kill using chemical miticides and silica powder treatment. Due to the infestation of mites in poultry the poultry farmers loose between 10% to 40% of their business. Once the mites are present in a flock it is impossible to exterminate the mites in one attempt with a treatment.
- chemical signals The secretions produced by different glands that can intervene in a chemical communication are known as chemical signals.
- chemical signals are those that participate strictly in intraspecific communications, which can be distinguished from those that are implicated in the interspecific communications.
- pheromones are substances released by the body that cause a predictable reaction by another individual of the same species, which substance may serve, for example, as a specific attractant, social communicator, sexual stimulant and the like.
- a number of different glands are known to produce pheromones in male mammals such as the submaxillary, salivary glands, the parathyroid glands and the sebaceous glands.
- pheromones are described in U.S. Patent Nos. 6,054,481 , 6,077,867 and 6,169,113.
- allelochemical signals that participate in interspecific communications are grouped under the general category of allelochemical signals.
- allelochemical signals are generally divided into two subgroups and their function affects the relationship between the emitter of the signal and the receiver of the message.
- an allomone is a hormone or substance produced by one species that has an effect upon another species, especially so as to benefit the emitting species. For example, attractive allomones emitted by certain flowers can attract various insects that can pollinate these flowers.
- a kairomone in contrast when the chemical signal emitted is in relation favorable to the receiver the sub grouping is known as a kairomone.
- a kairomone by definition, is a pheromone or substance that can attract other species and sometimes even natural enemies. The kairomones are sometimes implicated in locating a particular host by a parasite. For example, lactic acid that is emitted by human skin is a kairomone known for a number of Culicidae.
- Allomones and kairomones are natural substances that degrade causing no harm to the end user. These chemicals also do not cause immunity and are safe.
- the present invention provides a duck repulsive allomone and a chicken attractive kairomone, which can be used to treat arachnid infestations and which are safe and effective and can be used in the presence of other animals, including humans.
- the present invention provides a duck repulsive allomone that can be used to treat or prevent poultry infection with chicken mites or Northern fowl mites.
- the present invention provides a chicken attractive kairomone that can be used in conjunction with an adhesive material to trap chicken mites or Northern fowl mites.
- the present invention relates to a method of treating or preventing chicken mites or Northern fowl mites in birds such as hens, chickens, turkeys, ducks, geese and young chicks said method comprising administering to hens, chickens or young chicks in need of such treatment a pharmaceutically effective amount of a duck Dermanyssus repulsive allomone.
- the present invention thus relates to a duck repulsive allomone or a chicken attractive kairomone.
- the allomones and kairomones were derived from the uropygial gland of ducks and chickens, respectively.
- the duck repulsive allomone composition of the present invention can be used to repulse arachnids such as spiders, ticks and mites and thus prevents these arachnids from biting or feeding on hosts.
- the present invention provides a kairomone composition which can be used to attract arachnids. Once the arachnids are attracted to this kairomone that can be further trapped using an adhesive material or to induce the mite to feed on a miticide that is in the trap.
- the kairomone induces the feeding behavior and thus it is possible to enhance the mite to stick on any kind of adhesive surface such as, for example, polyethylene films.
- the present invention provides a duck repulsive allomone comprising bis(2-ethylhexyll) adipate and 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate and/or derivatives thereof and/or isomers thereof, as well as mixtures of bis(2-ethylhexyll) adipate or 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate with one or more derivatives with one or more isomers of bis(2-ethylhexyll) adipate or 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate and/or one or more isomers of the derivatives of bis(2-ethylhexyll) adipate or 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate.
- the present invention provides a duck repulsive allomone composition
- a duck repulsive allomone composition comprising about 45.0 to 55.0 (w%/w%) of bis(2-ethylhexyll) adipate and about 45.0 to 55.0 (w%/w%)2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate and/or esters, or salts, alcohols, ketones, ethers, aldehydes, sterols and amides derivatives of bis(2-ethylhexyll) adipate and 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate and/or isomers of bis(2-ethylhexyll) adipate and 2,2,4- trimethyl 1 ,3 pentanediol diisobutyrate and their derivatives, as well as mixtures of bis(2-ethylhexyll) adipate or 2,2,
- the present invention provides a chicken attractive kairomone composition
- a chicken attractive kairomone composition comprising 1-heptadecene, hepatdecane, 9-octadecene- ol 1 (oleyl alcohol), octadecane and/or derivatives thereof and/or isomers thereof, as well as mixtures of one or more of 1-heptadecene, hepatdecane, 9- octadecene-ol 1 (oleyl alcohol), octadecane with one or more derivatives of 1- heptadecene, hepatdecane, 9-octadecene-ol 1 (oleyl alcohol), octadecane with one or more isomers of 1-heptadecene, hepatdecane, 9-octadecene-ol 1 (oleyl alcohol), octadecane and/or one or more iso
- the present invention provides a chicken attractive kairomone composition
- a chicken attractive kairomone composition comprising about 23.5 to 26.5 (w%/w%) of 1- heptadecene, about 23.5 to 26.5 (w%/w%) of hepatdecane, about 23.5 to 26.5 (w%/w%) of 9-octadecene-ol 1 (oleyl alcohol) and about 23.5 to 26.5 (w%/w%) of octadecane and/or esters, or salts, alcohols, ketones, ethers, aldehydes, sterols and amides derivatives of 1 -heptadecene, hepatdecane, 9-octadecene-ol 1 (oleyl alcohol) and octadecane, and/or isomers thereof, as well as mixtures of one or more of 1-heptadecene, hepatdecane, 9-octadecen
- the allomone or the kairomone compositions described above can have varying concentrations of 0.1 % to 99.9%. However an increased effect is present when using the specific concentrations described herein. Moreover in the kairomone composition, at least two of the compounds selected from 1- heptadecene, hepatdecane, 9-octadecene-ol 1 (oleyl alcohol) and octadecane can be used in the formulation and still possess a kairomone effect.
- the present invention relates to a method of repulsing Arachnids, said method comprising administering a repulsing amount of a duck repulsive allomone to an animal in need of such treatment.
- a method of repulsing arachnids comprising administering to a human in need of such treatment a pharmaceutically acceptable amount of a duck repulsive allomone.
- arachnids include, but are not limited to, Dermanyssus gallinae, a tick or an Ornithonyssus .
- present invention also relates to a method of treating or preventing chicken mites or Northern fowl mites in hens, chickens, ducks, geese, turkeys, and young chicks said method comprising administering to hens, chickens or young chicks in need of such treatment a pharmaceutically effective amount of a duck repulsive allomone comprising about 45.0 to 55.0 (w%/ %) of bis(2-ethylhexyll) adipate and about 45.0 to 55.0 (w%/w%)2,2,4- trimethyl 1 ,3 pentanediol diisobutyrate and/or derivatives thereof and/or isomers thereof, as well as mixtures of bis(2-ethylhexyll) adipate or 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate with one or more esters, or salts, alcohols, ketones, ethers, aldehydes, sterols
- the present invention relates to a method of attracting Dermanyssus in buildings or hen houses comprising placing an attractive kairomone comprising about 23.5 to 26.5 (w%/w%) of 1-heptadecene, about 23.5 to 26.5 (w%/w%) of heptadecane, about 23.5 to 26.5 (w%/w%) of 9- octadecene-ol 1 (oleyl alcohol) and about 23.5 to 26.5 (w%/w%) of octadecane , as well as mixtures of one or more of 1-heptadecene, hepatdecane, 9- octadecene-ol 1 (oleyl alcohol), octadecane with one or more esters, or salts, alcohols, ketones, ethers, aldehydes, sterols and amides derivatives of 1- heptadecene, hepatdecane, 9-oc
- Fig. 1 is a gas chromatography/mass spectroscopy spectrum profile of the components found in the secretions of ducks and chickens from the uropygial gland.
- Fig. 2 is another gas chromatography/mass spectroscopy spectrum profile of the components found in the secretions of ducks and chickens from the uropygial gland.
- Fig. 3 is yet another gas chromatography/mass spectroscopy spectrum profile of the components found in the secretions of ducks and chickens from the uropygial gland.
- Fig. 4 is a graph demonstrating the types of solvents used.
- Chi stands for chloroform
- D-eth stands for diethyl ether
- Acet stands for acetone
- Eth 60% stands for 60% ethanol.
- D means the level of feeding of mites with skin washed with the solvent
- ⁇ stands for the level of feeding of mites after depositing on the skin a product washed with the another skin
- D stands for the level of feeding of mites after depositing on the washed skin a product that was washed and rinsed with water
- D means level of feeding of mites for the natural skin of chicken.
- Fig. 5 is a graph showing the percent of feeding of Dermanyssus gallinae with various concentrations of extracts derived from the chicken or duck uropygial gland with different concentrations of extract diluted with solubilized alcohol using a 1/10 to 1/160 dilutions.
- the first group of extracts was tested with washed chicken skin.
- the second group of extracts was tested with washed duck skin.
- the third group of extracts was tested with unwashed chicken skin and the fourth group of extracts was tested with unwashed duck skin.
- These extracts were from the duck uropygial gland; one was solubilized in alchohol (D) and the other in acetonitrile ( ⁇ ).
- Fig. 6 is a graph illustrating the percent of feeding of Dermanyssus gallinae with extracts of uropygial gland from the duck (D) or from chicken ( ⁇ ).
- Alone stands for feeding of the mites on washed skin;
- GL Ca stands for feeding of the mites with washed skin plus the extract from the uropygial glands from duck;
- LCa stands for the feeding of the mites from washed skin plus the product of washings from the duck.
- GI Pou stands for feeding of the mites on skin washed plus the extract from the uropygial gland of chicken.
- Lpou stands for stands for the feeding of the mites from washed skin plus the product of washings from the chicken.
- Fig. 7 is a graph showing the feeding percentage of Dermanyssus gallinae over a period of 11 days after hens were given the duck repulsive allomone of the present invention in the feedstuff.
- Fig. 8 is a graph showing the feeding percentage of Dermanyssus gallinae over a period of 11 days after chickens were given the duck repulsive allomone of the present invention in the feedstuff.
- Fig. 9 is a graph showing the feeding percentage of Dermanyssus gallinae over a period of 11 days after the hens were given the duck repulsive allomone of the present invention in the feedstuff and neutral blood.
- neutral blood is meant the blood of a chicken that has been fed with normal food.
- Fig. 10 is a graph illustrating the feeding percentage of Dermanyssus gallinae over a period of 11 days using the blood of hens supplemented with the duck repulsive allomone of the present invention.
- Fig. 11 are various graphs at different days illustrating the feeding percentage of Dermanyssus gallinae with six different groups tested with either a placebo or the duck repulsive allomone of the present invention placed in either water or in the feedstuff from day 0 to day 6.
- Fig. 12 are various graphs at different days illustrating the feeding percentage of Dermanyssus gallinae with six different groups tested with either a placebo or the duck repulsive allomone of the present invention placed in either water or in the feedstuff from day 10 to day 20.
- Fig. 13 is a graph at different days illustrating the feeding percentage of Dermanyssus gallinae on young chicks.
- D stands for the control;
- ⁇ stands for administration of the duck repulsive allomone in the feedstuff which was stopped;
- S$ stands for administering the duck repulsive allomone of the invention to the young chicks.
- Fig. 14 is a graph illustrating the feeding percentage of Dermanyssus gallinae on normal chicken skin with feather and nude chicken skin without feathers.
- D stands for the control;
- ⁇ stands for administering the duck repulsive allomone of the invention.
- Fig. 15 is a graph illustrating the feeding percentage of Dermanyssus gallinae on young chicks over a period of twenty-four days.
- D stands for the control;
- ⁇ stands for administering the duck repulsive allomone of the invention.
- Fig. 16 is a graph showing the grade of infestation on Day 0 prior to treatment and Day 25 after treatment with duck repulsive allomone (DRA) of chicken mites for each of the seven rows of hens treated.
- D stands for the control
- ⁇ stands for administering the duck repulsive allomone of the invention.
- Fig. 16 is a graph showing the grade of infestation on Day 0 prior to treatment and Day 25 after treatment with duck repulsive allomone (DRA) of chicken mites for each of the seven rows of hens treated.
- D duck repulsive allomone
- Fig. 17 is a graph showing the percent of infestation of chicken mites in each cage (coop) for each of the seven rows of hens at day 0 (untreated) and at day 35 after treatment with duck repulsive allomone (DRA).
- DRA duck repulsive allomone
- Fig. 18 is a graph showing the number of colonies per cage (coop) of chicken mites on Day 0 prior to treatment and Day 35 after treatment with duck repulsive allomone (DRA) in the seven rows of hens that were tested.
- Fig. 19 is a graph showing the diameter of the chicken mites on Day
- Fig. 20 is a graph showing the infestation of the droppings of the hens on Day 0 prior to treatment and on Day 35, after treatment with duck repulsive allomone (DRA) for the seven rows of hens that were tested.
- DRA duck repulsive allomone
- Fig. 21 is a graph showing the percent feeding of chicken mites on chicks with the duck repulsive allomone (DRA) extracted from the hen droppings.
- the DRA product was extracted with alcohol.
- Fig. 22 is a graph showing the percent of infestation of chicken mites in cage (coop) supports for each of the seven rows of hens at day 0 (untreated) and at day 35 after treatment with the duck repulsive allomone (DRA).
- Fig. 23 is a graph showing the percent feeding of chicken mites on chicks which were treated with the duck repulsive allomone (DRA) at different dilutions extracted from the uropygial glands of autopsied hens after treatment on day 35.
- DRA duck repulsive allomone
- Fig. 24 is a GC/MS spectrograph of the duck repulsive allomone (DRA) extracted from hens that were autopsied at 35 days after treatment. The peak for DRA can be seen around 13.23 on this spectrograph.
- DRA duck repulsive allomone
- Fig. 25 is a curve showing the amount of egg production of the hens treated with duck repulsive allomone (DRA).
- ⁇ represents the percent age of eggs that were laid; D represent the average egg weight; — represents the hen live weight (LW); and ⁇ represents the theoretical hen live weight (LW).
- Fig. 26 is a theoretical curve of the egg production of normal hens that were not treated with duck repulsive allomone (DRA). PREFERRED EMBODIMENTS OF THE PRESENT INVENTION
- arachnids encompasses all of the class Arachnida including the order Arachnida, Parasitiformes and Acarini.
- spiders included in the class Arachnida are spiders, ticks, as well as all types of mites, including the suborders of Mesostigmata, Astigmata and Prostigmata.
- birds and “avian” are used interchangeably and encompass any warm-blooded animal with feathers and wings that lays eggs and is usually able to fly. Examples of birds, includes, but is not limited to chicks, chickens, hens, ducks, geese, turkeys and the like.
- kairomone is meant a semiochemical that is produced by one organism to induce a response in an organism of another species. It produces a response that is unfavorable to the emitter.
- allomone is meant a semiochemical that is produced by one organism to induce a response in an organism of another species. It produces a response favorable to the emitter. For example, some plants produce allomones that repel insects and keep them from feeding.
- solution is meant a solid that is dispersed through a liquid either by being dissolved in it or being in suspension.
- exhancer composition is meant an active composition that is species-species specific in birds and which can be used to enhance or act synergistically with the allomone or kairomone composition to increase the effectiveness in specific species of the composition.
- the composition can include, for example only, bis(2-ethylhexyll) adipate and an alcohol derivative of 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate or an alcohol derivative of bis(2-ethylhexyll) adipate and an isomer of the alcohol derivative of 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate.
- the derivatives and isomers referred to herein have the exact same weight percentages as mentioned by their chemical counterparts.
- 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate have the same concentration of from about 45.0 to 55.0 (w%/w%).
- the same rationale also applies to the kairomone composition.
- isomers includes structural isomerism and spatial isomerism and refers to the isomers of the allomone composition and kairomone composition, as well as their derivatives.
- the present invention relates to the identification of an allomone composition and a kairomone composition that is derived from secretions around the uropygial gland of birds.
- the allomone composition of the present invention comprises a mixture of bis(2-ethylhexyl) adipate and 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate and/or derivatives thereof and/or isomers thereof and/or mixtures of bis(2-ethylhexyll) adipate or 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate with one or more esters, or salts, alcohols, ketones, ethers, aldehydes, sterols and amides derivatives of bis(2-ethylhexyll) adipate and 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate with one or more isomers of bis(2-ethylhexyl) adipate and 2,2,4- trimethyl 1 ,3 pentanediol diisobutyrate and/or one or more isomers of
- the allomone composition of the present invention comprises a mixture of about 45.0 to 55.0 (w%/w%) of bis(2-ethylhexyl) adipate and from about 45.0 to about 55.0 (w%/w%) of 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate and/or derivatives thereof and/or isomers thereof and/or mixtures of bis(2- ethylhexyll) adipate or 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate with one or more esters, or salts, alcohols, ketones, ethers, aldehydes, sterols and amides derivatives of bis(2-ethylhexyll) adipate and 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate with one or more isomers of bis(2-ethylhexyl) adipate and 2,2,4- tri
- the kairomone composition of the present invention comprises a mixture of about 23.5 to 26.5 (w%/w%) of 1-heptadecene, about 23.5 to 26.5 (w%/w%) of heptadecane, from about 23.5 to 26.5 (w%/w%) 9-octadecene-ol 1 (oleyl alcohol) and about 23.% to 26.
- the allomone or the kairomone compositions described above can have varying concentrations of 0.1% to 99.9%. However an increased effect is present when using the specific concentrations described herein. Moreover in the kairomone composition, at least two of the compounds selected from 1- heptadecene, hepatdecane, 9-octadecene-ol 1 (oleyl alcohol) and octadecane can be used in the formulation and still possess a kairomone effect.
- the allomone or kairomone compositions can also be attached to a chemical carrier provided that the bioactive structure of the composition is preserved.
- carrier molecules include, but are not limited to, resins, liposomes, crown compounds, carrier proteins, any kind of polymer and the like.
- compositions can be used in their pure form, as well as their derivative form such as esters, or salts, as well as alcohols, ketones, ethers, aldehydes, sterols and amides. Isomers of the pure and derivative forms are also encompassed in the present invention. These derivatives or isomers can replace one or more or all of the chemical components in the compositions of the present invention and have the same effects.
- the present invention comprises the composition in solution.
- the present invention provides in solution of about 45.0 to 55.0 (w%/w%) of bis(2-ethylhexyl) adipate and from about 45.0 to about 55.0 (w%/w%) of 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate of a duck Dermanyssus repulsive allomone and/or derivatives thereof and/or isomers thereof and/or mixtures of bis(2-ethylhexyll) adipate or 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate with one or more esters, or salts, alcohols, ketones, ethers, aldehydes, sterols and amides derivatives of bis(2-ethylhexyll) adipate and 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate with one or more isomers of
- compositions and solutions are used separately as either a repulsive composition or an attractive composition.
- the composition may be in the form of a solution, aerosol spray, gel, slow release matrix, shampoo, soap, lotion, ointment and the like.
- the composition can also be placed in liposomes, in a diffuser, in any kind of polymer and can be microencapsulated.
- the allomone solution and compositions of the present invention can also be placed in feedstuff and be fed to the birds or other animals. It can also be placed in water and drunk by birds or other animals.
- concentration of the above-mentioned allomone and kairomone compositions may vary depending upon the final form of use. However, the concentrations of these compositions that are utilized and their concentration may be ascertained and tested according to the methods set forth in the present invention.
- the allomone and kairomone compositions can be diluted in any nonaqueous solvent to form the solution of the present invention.
- Solvents such as, alcohol, diethyl ether, chloroform, ethanol, benzene, propyl alcohol, isopropanol, 2-propanol, acetone polysorbate 80 and the like. Combinations of these solvents can also be used.
- an aqueous solution that can be ingested such as water or in vegetal or animal oil or any kind of fat product used to prepare animal or human food. They can also be added as a solid composition directly to the foodstuff.
- the chicken Dermanyssus attractive kairomone can also be placed on sticky paper such as cellulosic paper or in a box that can attract and trap the arachnids.
- an adhesive is also used for entrapment purposes.
- Such an adhesive can be either a natural adhesive or a synthetic adhesive. Typical natural adhesives include starches and modified starches.
- the synthetic adhesives that can be used in the present invention include, but are not limited to polyacrylates, polyvinyl chlorides, silicones, urethanes, styrene copolymers, polyvinylacetates and the like.
- the adhesive layer is generally between 0.02 to 0.5 inches thick.
- the entrapment box or container can be made of any material such as cardboard for interior use or plastic or polymers for exterior use.
- the attractive kairomone is spread throughout the interior and the container or box has one or more entry passages such that the arachnids can enter freely and be entrapped by the adhesive substance.
- concentration of the kairomone is from about 0.015 ppm to 0.5 ppm in this application for the container.
- the present allomone compositions can be applied to a variety of objects that Arachnids come in contact with such as walls, tents, beds, carpets, clothes and the like. Moreover, the present allomone composition can be applied topically on animals or humans to repel arachnids such as mites, ticks, spiders and the like.
- the present invention also relates to a method of repulsing Arachnids, said method comprising administering a repulsing amount of a duck repulsive allomone to a animal in need of such treatment. Included in the category of animals is man, since chicken mites are zoonotic parasites and is effective to avoid feeding in humans.
- the present invention includes a method of treating or preventing chicken mites or Northern fowl mites in hens, chickens, ducks, turkeys, geese and young chicks said method comprising administering to hens, chickens or young chicks in need of such treatment a pharmaceutically effective amount of a duck repulsive allomone comprising about 45.0 to 55.0 (w%/w%) of bis(2-ethylhexyll) adipate and about 45.0 to 55.0 (w%/w%)2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate and/or derivatives thereof and/or isomers thereof and/or mixtures of bis(2-ethylhexyll) adipate or 2,2,4-trimethyl 1 ,3 pentanediol diisobutyrate with one or more esters, or salts, alcohols, ketones, ethers, aldehydes, sterols and amides derivatives of
- the present invention includes a method of attracting Dermanyssus in buildings or hen houses comprising placing an attractive kairomone comprising about 23.5 to 26.5 (w%/w%) of 1-heptadecene, about 23.5 to 26.5 (w%/w%) of heptadecane, about 23.5 to 26.5 (w%/w%) of 9- octadecene-ol 1 (oleyl alcohol) and about 23.5 to 26.5 (w%/w%) of octadecane and/or derivatives thereof and/or isomers thereof and/or mixtures of one or more of 1-heptadecene, hepatdecane, 9-octadecene-ol 1 (oleyl alcohol), octadecane with one or more esters, or salts, alcohols, ketones, ethers, aldehydes, sterols and amides derivatives of 1-heptadecene, hepatde
- this procedure involved swabbing the uropygial area of ducks or chickens with a sterile compress and analyzing the composition of the secretions with gas chromatography/mass spectroscopy. From the chromatographs the chemical compositions that were prevalent in the secretions were further analyzed using a computer database, which are known in the art and the chemical make-up was determined for the allomone composition and the kairomone composition.
- a computer database which are known in the art and the chemical make-up was determined for the allomone composition and the kairomone composition.
- Example 1 Isolation and Analysis to identify allomones and kairomones from chickens and ducks
- the samples were obtained from ducks and chickens by applying a sterile compress to the uropygial gland or tail gland and secretions from this gland were collected on the compress.
- the compress was immediately placed in a flask containing 10 ml of dichloromethane and the flask was agitated several times such that the secretion was deabsorbed.
- the sample was then analyzed by gas chromatography/ mass spectroscopy (GC/MS) using a Turbo Mass GC/MS from Perkin-Elmer.
- GC/MS gas chromatography/ mass spectroscopy
- the column utilized was a JW type DB 5 MS having a length of 30 m a width of 0.25 mm and a film of 0.25 ⁇ m.
- the split used was 1/20 and the split/split less used was 45 seconds. 2.0 ⁇ l was injected.
- the detection was effectuated on impact using a positive electronic impact (EI+) at an energy of 70 eV at 180°C. This technique was used to separate the molecules in a reproducible and characteristic manner. A data base, known in the art was then interrogated to interpret what molecules in the samples were the closest to the spectra obtained.
- EI+ positive electronic impact
- the attractive kairomone in chickens was composed of the following composition: about 23. 5 to 26.5 (w%/w%) heptadecene-1 ol about 23. 5 to 26.5 (w%/w%) heptadecane/heptadecene about 23. 5 to 26.5 (w%/w%) 9-octadecene-ol 1 (oleyl alcohol) about 23. 5 to 26.5 (w%/w%) octadecane/octadecene
- the repulsive allomone from ducks was found to be composed by of the following composition: about 45.0 to 55.0 (w% w%) bis(2-ethylhexyl) adipate about 45.0 to 55.0 (w%/w%) 2,2,4-trimethyl-1 ,3 pentanediol diisobutyrate
- the molecules present on the skin are essentially liposoluble and to extract them it is necessary to use an organic solvent.
- organic solvents are extremely irritating to the skin and risk to alter the cutaneous texture, which could induce a modification of behavior in a parasite. Therefore, the following experiments were performed to test different solvents and to identify those which do not alter the cutaneous texture of the skin, as well as being less noxious for the skin as well as the parasite or arachnid.
- Four different solvents were tested; namely chloroform, diethyl ether, acetone and 60% ethanol. For each solvent the variation of the amount of feeding Dermanyssus gallinae was undertaken for an excised patch of chicken skin washed with the particular solvent and the natural skin.
- each skin was washed three times with 0.5 ml of solvent.
- the skin was washed in vitro and then fed to the arachnids (Dermanyssus gallinae).
- arachnids Dermatasus gallinae
- 0.5 ml aliquot of solvent was placed on the already washed skin and was permitted to evaporate.
- the skin was washed in a liquid obtained after washing a different chicken or duck skin. For 60% ethanol, after washing and letting this solvent evaporate, the skin was again washed twice with 0.5 ml water.
- the skin of chickens and ducks was utilized in this example to search for the presence of kairomones and allomones in these two different birds.
- the skin of the ducks and chickens were washed with 0.5 ml 60% ethanol three times and the aliquots from these washings were collected. 0.5 ml of the washing aliquots were then redeposited on the same skin another three times and an one hour period was maintained between each washing to permit the alcohol to evaporate. After the three last washing, the skin was washed once with 0.5 ml of deionized water.
- Extracts from the uropygial gland or tail gland were deposited on the chicken skin or duck skin washed with ethanol. These extracts were diluted 1/20 prior to being deposited. This dilution takes into account the volume of the raw secretion that was found settled throughout the entire body.
- Dermanyssus gallinae (30 per tube) were applied to either the chicken skin or the duck skin. Three tubes were used in this experiment, each containing 30 Dermanyssus gallinae. The results are set forth in Figure 5. From these experiments it was concluded that there exists on the skin one or more substances that potentiates the feeding of the Arcadnida and is a kairomone. This kairomone is present in the uropygial or tail gland. There also exists on the skin of a duck one or more substances that have a repulsive effect on the Arcadnida and are also found in the uropygial or tail gland. These substances are allomones.
- Extracts of the uropygial gland of the duck and chicken were diluted 1/10, 1/20, 1/40, 1/80, and 1/160 with ethyl alcohol.
- Four pieces of absorbent papers were placed in a Petri dish. On one of the papers a known miticide was placed (LD 100 in 12 hours at 1.20 of the dose prescribed.) On the other paper the products of extraction were placed. The mites were introduced into the Petri dish. The Petri dish was closed and placed in a dry area for 12 hours. After 12 hours the dead mites were counted. The results are shown for the extracts in Figure 6.
- a cage was infested with Dermanyssus gallinae at a level of infestation of 5/8. The maximum observed in breeding is 6/8. This means around 60 mites per cm 2 .
- the cage was separated into two compartments. One compartment contained only the feedstuff. This separation permitted a free circulation of the mites between both compartments but not the young chicks, which were restricted to the compartment that did not contain the feedstuff. The two zones of the cage were equally infected with the chicken mites. The young chicks used in this example were a day old.
- the chicks were separated into two lots. Lot A was fed with a feedstuff supplemented with Duck Repulsive Allomone (hereinafter DRA) and lot B with regular feedstuff at Day 1 . 800 ⁇ g/200 g of DRA, thus 4 mg/kg was added to the feedstuff. The quantity of feedstuff eaten was for the chicks on the average from 15 g to 20 g.
- DRA Duck Repulsive Allomone
- DRA Duck Repulsive Allomone
- Example 9 In this experiment neutral blood was used and the hens and chickens skin was supplemented with the DRA (p ⁇ 0.0007) and the same groups and treatment were used as in Example 4 (see Table) The mites fed at the same level as previously in Example 5. The results are shown in Figure 9.
- Figure 10 confirms that the DRA does not enter into the blood of the animals tested. This test was effectuated using a blood index of Dermanyssus gallinae. Also the substances ingested with the feedstuff could be absorbed in the course of digestion. The use of neutral skin with the blood of the animal supplemented with DRA permits to demonstrate that the DRA was found on the skin and thus excreted from the animal cutaneously.
- the mites were induced to feed through a piece of normal skin, but the proposed blood was a sample of blood obtained from chickens fed with DRA.
- DRA Duck Repulsive Allomone
- Groups 2 and 4 constitute the placebos while Group 1 is the control.
- Figures 11 and 12 at day 0 to day 20 indicate the results in terms of feeding until the slaughtering of the chickens.
- Figure 1 1 indicates the significant differences between the control group and the placebo group starting at day 4 for Group 3 for all of the tests
- Group 1 , group 2 and Group 4 are significantly important.
- This example illustrates the time of apparition of protection with young chicks in comparison with hens.
- the procedure was the same as that in Example 4; i.e., the DRA was added to the feedstuff.
- DRA i.e., nude skin and skin with feathers.
- the skins that were treated were those of chickens fed with normal food or with DRA. Half of the skin feathers were removed and half the skin feathers were maintained.
- a solution of about 23. 5 to 26.5 (w%/w%) heptadecene-1 , about 23. 5 to 26.5 (w%/w%) heptadecane, about 23. 5 to 26.5 (w%/w%) 9-octadecene-ol 1 (oleyl alcohol) and about 23. 5 to 26.5 (w%/w%) octadecane is made.
- the interior of container made of plastic and having openings is saturated with a polyacrylate adhesive material in order to entrap mites.
- the kairomone solution is then added to the interior of the container which is then placed in a hen house.
- the mites which are baited with the kairomone solution are then entrapped in the container after a few days.
- the container is then disposed of.
- Example 11 The same container with the kairomone as in Example 11 is used in this example.
- the container was placed in a window well outside of a house where numerous black widow spiders were nesting.
- the black widow spiders which are baited with the kairomone solution are then entrapped in the container after a few days.
- the container is then disposed of.
- Example 13 A dog is washed with a shampoo comprising about 45.0 to 55.0
- Example 15 The same method is applied as in Example 13, but cats are used. The cat is later searched for ticks and none were found since the allomone in the shampoo repulsed this arachnid.
- Example 15 The same method is applied as in Example 13, but cats are used. The cat is later searched for ticks and none were found since the allomone in the shampoo repulsed this arachnid.
- a child is washed with a shampoo/ soap comprising about 45.0 to
- a chicken breeder is washed with a soap comprising about 45.0 to
- Example 17 This example illustrates the efficacy of the Duck Repulsive Allomone
- the hen house was first visited by the persons involved in the study and an initial inspection was undertaken of the hen house infected with Dermanyssus gallinae with the head aviculturist of the hen house being present.
- the hen house was inspected by the investigators wearing boots and gloves. The hens were then divided into 7 rows in the hen house and each row was assigned a number of 1 to 7. The head aviculturist was requested to choose two hens randomly from each of the seven rows of hens. Blood was taken from each of the randomly chosen hens and an autopsy of the hens was also performed. 4 mis of blood was taken from the alar vein of each hen. Part of the blood was placed in a test tube that did not contain any chemical additives and the other part was placed in a test tube containing EDTA. The blood samples were then placed in an isothermic recipient that had refrigerating blocks. They were analyzed the next day in a laboratory.
- the randomly chosen hens were sacrificed and subjected to a complete autopsy, including a search for external parasites.
- Solution 1 a titrated 4% (w%/w%) solution of DRA 50% (w%/w%) of bis(2-ethylhexyl) adipate and 50% (w%/w%) 2,2,4 trimethyl 1 ,3 pentanediol diisobutyrate) and brought to 100 ml. with ethanol. This product was placed in water bottles of 2.5 liters.
- Solution 2 a titrated 4% (w%/w%) of DRA 50% (w%/w%) of bis(2- ethylhexyl) adipate and 50% (w%/w%) 2,2,4 trimethyl 1 ,3 pentanediol diisobutyrate) containing 5% (w%/w%) of polysorbate 80 and brought to 100 ml using ethanol. This product was placed in water bottles of 5 liters.
- Solution 3 a titrated 4% (w%/w%) of DRA 50% (w%/w%) of bis(2- ethylhexyl) adipate and 50% (w%/w%) 2,2,4 trimethyl 1 ,3 pentanediol diisobutyrate) containing 5% (w%/w%) of polysorbate 80 and brought to 100 ml using water. This product was placed in water bottles of 4 liters.
- the first solution 1 was presented to the aviculturist at V1.
- a control was performed by using lots of two successive generations of the DRA product.
- Telephonic interviews with the aviculturist were undertaken to discuss problems associated with administering the DRA products with the investigators. In the course of one of the telephonic interviews, it was decided to evaluate the formulation of the product.
- solution 1 was administered in water bottles.
- the very feeble miscibility of solution 1 in water required the atomization in each water bottle by the reservoir in each row of hens.
- Solution 1 was placed in the water bottle with a syringe of 50 ml and each dose was then atomized in the reservoir by passage through a needle possessing an exterior diameter of 0.5 millimeters. This operation was performed morning and night. Duration of Treatment
- the treatment was consumed during a period of these 32 days. During the first 10 days, the first solution was used as the treatment. The following 6 days, the second solution was administered as the treatment and in the 16 remaining days, solution 3 was administered as the treatment. The amount of product consumed during this 32 day treatment is set forth in the following Table 7: Table 7
- solutions 2 and 3 The rate observed for the calculation of solutions 2 and 3 can be explained by the method of administration of these two solutions.
- the aviculturist placed a variable amount of these products (solutions 2 and 3) in a very small volume of a salad bowl prior to aspirating the dose which was administered.
- a theoretical quantity which was consumed was therefore calculated.
- Samples were also taken from each of the different reservoirs of water in which the treatment was placed. The samples were then analyzed in a laboratory to ascertain whether the chemical composition of the DRA product was altered or not. The observations maintained by the aviculturist during the experiment were recuperated.
- the efficacy of the product was evaluated using three parameters: parasitological parameters, medical parameters and zootechnical parameters.
- arachnid population was regrouped and tests were performed to evaluate the vigor of the arachnids, the number of arachnids and the amount of infestation in different zones of the hen house. In vitro tests were performed to measure the amount of inhibition of feeding of the arachnids in the presence of the DRA in the uropygial gland secretions of the autopsied hens and the droppings obtained in visit 2. For each category of the parasitological parameters that were measured, the results for each row were calculated separately. A comparison of the total parasites was compared before and after treatment, which results were also compared to those performed in the laboratory.
- the hens that had their blood taken were also sacrificed and an autopsy was performed on each hen.
- This autopsy also included for the visit 1 hens which were sacrificed, a removal of a trace of the mucosa Caecal from the wall of the Caecal which was taken and placed in 10% formalin and a histopathologic evaluation was performed.
- the wall of the gizzard and a hepatic lobe were removed to clarify the origin of the cahectic state which is indicative of a massive bile reflux in the light of the gizzard, observed in certain hens in row 4.
- the results of this analysis permitted the evaluation of the impact of parasites for the occurrence of opportunistic ailments and provides some information concerning the physiological state of the hens.
- the degree of infestation was evaluated by collecting the droppings from the floor.
- the dry droppings are privileged hiding place for the parasites and their evacuation from the hen house risks recontamination of the other hen houses with the parasites.
- the results also showed that the DRA product prevents the Dermanyssus to eat. Once an arachnid population is reformed in the middle of the hen house, recontamination is unavoidable.
- Figure 20 shows the data obtained and the efficacy of the DRA product of the present invention on the hen house of the gathered droppings which shows a mean average grade of infestation of 5 prior to the treatment to a grade of infestation inferior to 1 after the treatment.
- Tests Parasitic in vitro Three parameters were tested: the presence of DRA in the droppings, the present of DRA in the uropygial gland secretions of the hens that were sacrificed at visit 2 and the sensitivity of the mites present in the hen house. Presence of DRA in the droppings Hen droppings taken from the hen house were extracted using alcohol. The extracts of the hen droppings that were treated with DRA were applied to the skin of the chicks and protected the chicks against Dermanyssus gallinae.
- the doses were chosen at 1 to 32 times the dose commercially given on the products' instructions. Amitraze was the most efficient miticide at the prescribed dose. All of the other miticides tested had a performance of less than 50% mortality rate. At four times the dose, Aphamethrine had an 85% efficacy rate. However, in these commercial products only 16 times the recommended dosage was effective to kill the chicken mites. Even if the products were effective it was noted that the colonies had a tendency to reform after the treatment.
- the results mentioned in this section are only qualitative and are only a comparison of the evolution of the grade of infestation of a hen cage using a living host.
- Two populations of mites having a similar size were placed in two distinct chicken cages with a live chick.
- the first population was the control in which no treatment with DRA was administered and the Dermanyssus that were used in this example were obtained from a different source.
- the second chicken cage contained Dermanyssus that were collected from the hen house that was treated after visit 2.
- the control population had an increase of two points on the graduation scale than the visit 2 population.
- the virulence of the chicken mites in the control group at a grade 4 resulted in the chicks dying, while with the visit 2 population of mites, the chicks survived.
- the Dermanyssus from visit 2 were killed by immersion in CO 2 at - 78°C to provoke a brutal death without draining their digestive tubes.
- the chicken mites were then placed in dichloromethane and the analysis of the solvent was performed using GC/MS.
- the chromatographs are illustrated in Figure 24 and show the two peaks characteristic of DRA. (at 13.23)
- the adsorption of the two molecules which are strongly hydrophobic by the cuticle of the mites was not surprising since the cuticles of mites have a structure that has a high affinity for hydrophobic compositions.
- the lower levels of the granulocytes from the blood of the DRA treated hens in visit 2 as compared with visit 1 confirm the regression of chicken mite infestation.
- a drastic diminution of granulocytes and eosiniphils is indicative of the lowering of the disturbance of the hens introduced by the biting of the chicken mites, which results in an inflammatory response or a state of stress introduced by repeated irritation.
- the results of the leucocytes/lymphocytes is considered as a reliable medical indication of stress and this value was significantly lower in the blood taken from the hens at visit 2 as compared to the blood taken from the hens at visit 1 which were not treated with DRA.
- Electrophoresis was performed on the blood taken from the hens at visit 1 and visit 2 to determine the blood protein content of the samples.
- Table 10 shows the ratio between albumin/globulins (A/G) that evaluates the inflammation in the animals. This Table reflects the values obtained from visit 1 (V1) and visit 2 (V2).
- the visit 2 hens that were autopsied did not have any macroscopic anomaly.
- the uropygial glands were very voluminous. Their content was very different from that described above for the visit 1 hens; it was very oleaginous and had an amber to orange opaque color. The appearance of the uropygial gland of the visit 2 hens is the same that was observed in the duck.
- the secretions were taken and used in the in vitro feeding tests described above. During the trial the investigators noticed a high mortality rate for those hens in row 4. The hens in row 4 had a phase of anorexia accompanied by sleeplessness before dying. Three additional autopsies were performed on the dead hens from row 4. These hens were cachectic and had a muscular atrophy particularly noticeable on their sternum muscles. Also noted was uterine regression and the mature follicles were blocked.
- the gizzard was examined in the sacrificed hens from row 4.
- the cavity of the gizzards contained the exterior of cereal and several fragments of food which were difficult to identify.
- the content of the gizzards was saturated with bile and contained a green content, which was the same for the mucous membrane. This indicated that the hens fasted from food.
- the hepatic parenchymal of two of the hens had a tanned aspect which is however not the tanned aspect which is typical of hens infected by Salmonella.
- Zootechnical Parameters The production of eggs The production of eggs was also analyzed and the results are presented in Figure 25.
- the rate of the collected down-classed eggs is a variable that is interesting to observe because it is a principal component of the profitability of the group of hens.
- the mean results before and after treatment permits one to observe an augmentation in the ratio of eggs which were down-classed.
- the five last weeks during the duration of the treatment one observes an augmentation in egg production compared to the normal egg production.
- the ratio of the eggs that were down-classed rises slightly in the two first weeks of the treatment with DRA then reaches a plateau and the size then rises at the end to generally pass 15%.
- the mean weight of the eggs decreases after 4 weeks with the start of the treatment of DRA. This margin is not significant, but is interesting since the Figure 25 permits a comparison of the weight of the produced eggs before and after the treatment which shows the augmentation of the mean weight of the eggs.
- DRA in the water of the hens perturbs the hens due to the different taste of the water or digestive problems associated with taking the treatment.
- the quantity of water which was consumed per day was constant.
- DRA has a craving influence on the hens, which is not the case.
- the production of eggs was very favorable using the DRA treatment. DRA permits the diminution of food consumption by the hens and maintains the production classic where the lowering of the Food Consumption Index augments the raw margin of the hen breeder.
- the entire parasitological results show an important regression of the population of Dermanyssus in the course of the testing with DRA. This regression, following the kinetics which was observed during the assays in vitro, started on the fifth day of the treatment.
- the invasion of the parasitic population starts by the vulnerable stages that are the nymphs N2 stage then the females of type 1 and then the males.
- the forms of resistance in the nymphs N1 type and females of type 2 show a significant survivorship that diminished and associated with major modifications in the social behavior.
- the tests concerning the feeding of the mites in vitro with the uropygial secretions taken from visit 2 confirm the presence of DRA in the secretions and confirm the choice of administration.
- the components of DRA after reabsorption by the digestive tract are excreted by the uropygial gland.
- the water reservoir in row 4 had more calcium deposits than in the other 6 reservoirs. Also green algae were colonizing in this reservoir in certain calcium deposits.
- This water reservoir was also placed just next to the ventilation system of the air conditioning and temperature of the water was elevated.
- the difference in the water reservoir in row 4 accounts for the differences obtained in the results as compared to the other DRA treated rows.
- the therapeutic implications of DRA are limited to the parasitological domain.
- the zootechnical results are in fact indicative of the suppression of the chicken mites when DRA is administered.
- the objective of this example was to test the efficacy of DRA in hen houses with egg laying hens. This trial lasted for a duration of 4 weeks.
- 6 buildings, B1 to B6 housing 31 ,000 hens per building were used.
- the hens utilized in this example were Isabrown (brown egg laying) hens.
- the age of the hens differed in the buildings. In buildings 1 , 2 and 3 (referred to hereafter as B1 , B2 and B3) the hens had an age of 29 weeks, while in building 4, 5 and 6 (referred to hereafter as B4, B5 and B6) the hens had an age of 57 weeks.
- thermonebulizer 12 ml of DRA (50% (w%/w%) of bis(2-ethylhexyl) adipate and 50% (w%/w%) 2,2,4 trimethyl 1 ,3, pentandiol diisobutyrate) at a 4% (w%/w%) concentration diluted in 12 liters of product into the thermonebulizer and 3 reservoirs were maintained in this building.
- the DRA (50% (w%/w%) of bis(2-ethylhexyl) adipate and 50% (w%/w%) 2,2,4 trimethyl 1 ,3, pentandiol diisobutyrate) at a 4% (w%/w%)concentration was administered in the drinking water. This provides the treatment nonstop to the hens and the duration of treatment varied as indicated in the following Table 11.
- a second treatment was undertaken after a control visit at day 15 (15 days after he start of the treatment).
- the quantities which were distributed for the building B2 to B6 were 50 ml of the DRA in a reservoir of 500 liters. No control was run this example. Table 11
- the hen house buildings were infected by red chicken mites for a duration of 7 years prior to this trial.
- the different solutions to minimize the red chicken mites that were previously utilized were different light cycles of 4 hours on/ 2 hours off during day and night, treatments (just for 5 flocks) with Sevin, Cepoux and Actograde, which are commercially available products used to treat red chicken mites.
- the treatments were not successful which has no influence on the hens in this trial.
- the buildings were situated as follows:
- the evaluation of the grade of infestation of red chicken mites was according to the method of Bruneau, supra. A first evaluation was effectuated in the buildings to verify the state of the infestation of the buildings and the different red chicken mites that were present. After, a diagnostic study of the state of the population of the red chicken mites after their removal from the buildings was effectuated on Day 1 in a laboratory. Two species of chicken mites were present in the hen house buildings Dermanyssus gallinae (DG) and Dermanyssus hirundinis (DH).
- DG Dermanyssus gallinae
- DH Dermanyssus hirundinis
- the population of the infestation of the chicken mites did not change during this trial. 85% of the chicken mites present were Dermanyssus gallinae and the rest were Dermanyssus hirundinis.
- Building 1 The colonies of mites were still there. One noted the amelioration of the situation of the parasites in this building. There were no mites on the collected eggs. Less than 1 % of the eggs had spots that were ruined by the mites feeding thereon. In the laboratory the mites appeared perfectly functional; i.e., they flee from light, reform their colonies even though dispersed and eat normally. The treatment is being further checked in this building.
- Buildings B1 , B2 and B3 the chicken mites did not react to light or other mechanical stimulation. The mites were incapable of feeding. In Building 1 , the colonies reformed at greater than 60% after their desegregation. The reformation of the colonies in building 2 and building 3 did not exceed 60%.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
Abstract
Description
Claims
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004514863A JP4783569B2 (en) | 2002-06-19 | 2003-06-19 | Allomone repellent and kairomone attractant composition for controlling spiders |
BR0311899-1A BR0311899A (en) | 2002-06-19 | 2003-06-19 | Composition, methods of repelling arachnids, treating or preventing chicken mites or northern bird mites in chickens, chickens and young chicks and attracting arachnids, and solution. |
AT03760695T ATE543502T1 (en) | 2002-06-19 | 2003-06-19 | ALLOMONE REPELLANTS FOR CONTROLLING ARACHNIDAE |
EP03760695A EP1531840B8 (en) | 2002-06-19 | 2003-06-19 | Allomone repulsive compositions for controlling arachnids |
ES03760695T ES2379253T3 (en) | 2002-06-19 | 2003-06-19 | Alomonas repellent compositions to fight arachnids |
CA2490680A CA2490680C (en) | 2002-06-19 | 2003-06-19 | Allomone repulsive and kairomone attractive compositions for controlling arachnids |
MXPA04013003A MXPA04013003A (en) | 2002-06-19 | 2003-06-19 | Allomone repulsive and kairomone attractive compositions for controlling arachnids. |
AU2003246371A AU2003246371A1 (en) | 2002-06-19 | 2003-06-19 | Allomone repulsive and kairomone attractive compositions for controlling arachnids |
CNB03817409XA CN100393220C (en) | 2002-06-19 | 2003-06-19 | Allomone repulsive and kairomone attractive compositions for controlling arachnids |
US11/003,530 US8828921B2 (en) | 2002-06-19 | 2004-12-06 | Allomone repulsive and kairomone attractive compositions for controlling arachnids |
US14/321,294 US9844217B2 (en) | 2002-06-19 | 2014-07-01 | Allomone repulsive and kairomone attractive compositions for controlling arachnids |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39005902P | 2002-06-19 | 2002-06-19 | |
EP02291534.2 | 2002-06-19 | ||
EP02291534 | 2002-06-19 | ||
US60/390,059 | 2002-06-19 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/003,530 Continuation US8828921B2 (en) | 2002-06-19 | 2004-12-06 | Allomone repulsive and kairomone attractive compositions for controlling arachnids |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004000337A1 true WO2004000337A1 (en) | 2003-12-31 |
Family
ID=44798143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/007143 WO2004000337A1 (en) | 2002-06-19 | 2003-06-19 | Allomone repulsive and kairomone attractive compositions for controlling arachnids |
Country Status (12)
Country | Link |
---|---|
US (2) | US8828921B2 (en) |
EP (1) | EP1531840B8 (en) |
JP (1) | JP4783569B2 (en) |
CN (1) | CN100393220C (en) |
AT (1) | ATE543502T1 (en) |
AU (1) | AU2003246371A1 (en) |
BR (1) | BR0311899A (en) |
CA (1) | CA2490680C (en) |
ES (1) | ES2379253T3 (en) |
MX (1) | MXPA04013003A (en) |
PT (1) | PT1531840E (en) |
WO (1) | WO2004000337A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7712522B2 (en) | 2003-09-05 | 2010-05-11 | Enventure Global Technology, Llc | Expansion cone and system |
US7819185B2 (en) | 2004-08-13 | 2010-10-26 | Enventure Global Technology, Llc | Expandable tubular |
US7886831B2 (en) | 2003-01-22 | 2011-02-15 | Enventure Global Technology, L.L.C. | Apparatus for radially expanding and plastically deforming a tubular member |
FR2969463A1 (en) * | 2010-12-23 | 2012-06-29 | Solvay | Parasiticide combination, useful to control the development of parasites on animals, comprises first portion containing parasiticide composition containing alkali metal bicarbonate and second portion having parasite attractive substance |
US10500183B2 (en) | 2014-06-19 | 2019-12-10 | Attillaps Holdings | Acetylcholinesterase inhibitors for treatment of dermatological conditions |
US10709135B2 (en) | 2013-07-29 | 2020-07-14 | Attillaps Holdings | Organophosphates for treating afflictions of the skin |
US11446241B2 (en) | 2013-07-29 | 2022-09-20 | Attillaps Holdings Inc. | Treatment of ophthalmological conditions with acetylcholinesterase inhibitors |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7835030B2 (en) * | 2004-03-26 | 2010-11-16 | Lexmark International, Inc. | Processing print jobs |
US7817302B2 (en) * | 2004-03-26 | 2010-10-19 | Lexmark International, Inc. | Optimizing raster operation functions during print job processing |
US20050213142A1 (en) * | 2004-03-26 | 2005-09-29 | Clark Raymond E | Optimization techniques during processing of print jobs |
US8392999B2 (en) * | 2005-12-19 | 2013-03-05 | White Cyber Knight Ltd. | Apparatus and methods for assessing and maintaining security of a computerized system under development |
US9314018B2 (en) | 2012-06-25 | 2016-04-19 | Institut de Recherche en Semiochimie et Ethologie Appliquee | Feline scratch marking semiochemicals |
JPWO2016159214A1 (en) * | 2015-04-01 | 2018-02-01 | 協友アグリ株式会社 | Combination of harmful arthropod attractant compound and repellent compound |
FR3060258B1 (en) | 2016-12-15 | 2019-07-12 | Universite Paul-Valery Montpellier 3 | ANTI-ACARIUS COMPOSITION |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4853217A (en) * | 1986-05-10 | 1989-08-01 | Toyo Seikan Kaisha, Ltd. | Methods and compositions for controlling the pear leaf blister moth, Leucoptera scitella |
US20010021378A1 (en) * | 1996-05-09 | 2001-09-13 | Dieter Hofer | Pesticide |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0670305B2 (en) * | 1990-08-24 | 1994-09-07 | 大阪化成株式会社 | A method of subjecting a textile product to light-proof and dry-cleaning-proof indoor dust mites lethal treatment |
JPH09169608A (en) * | 1995-12-20 | 1997-06-30 | Mitsui Toatsu Chem Inc | Antimicrobial treatment for vinyl chloride resin molded product |
US5882636A (en) * | 1997-07-21 | 1999-03-16 | Tevco, Inc. | Phthalate free nail polish enamel composition |
JP4108171B2 (en) | 1998-03-03 | 2008-06-25 | 三菱電機株式会社 | Image synthesizer |
US6391943B2 (en) * | 1998-09-04 | 2002-05-21 | Trident International, Inc. | High resolution pigment ink for impulse ink jet printing |
JP2000302607A (en) * | 1999-04-21 | 2000-10-31 | Kurita Water Ind Ltd | Industrial antimicrobial agent composition |
-
2003
- 2003-06-19 CN CNB03817409XA patent/CN100393220C/en not_active Expired - Fee Related
- 2003-06-19 PT PT03760695T patent/PT1531840E/en unknown
- 2003-06-19 BR BR0311899-1A patent/BR0311899A/en not_active Application Discontinuation
- 2003-06-19 AT AT03760695T patent/ATE543502T1/en active
- 2003-06-19 CA CA2490680A patent/CA2490680C/en not_active Expired - Fee Related
- 2003-06-19 MX MXPA04013003A patent/MXPA04013003A/en active IP Right Grant
- 2003-06-19 JP JP2004514863A patent/JP4783569B2/en not_active Expired - Fee Related
- 2003-06-19 EP EP03760695A patent/EP1531840B8/en not_active Expired - Lifetime
- 2003-06-19 WO PCT/EP2003/007143 patent/WO2004000337A1/en active Application Filing
- 2003-06-19 ES ES03760695T patent/ES2379253T3/en not_active Expired - Lifetime
- 2003-06-19 AU AU2003246371A patent/AU2003246371A1/en not_active Abandoned
-
2004
- 2004-12-06 US US11/003,530 patent/US8828921B2/en active Active
-
2014
- 2014-07-01 US US14/321,294 patent/US9844217B2/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4853217A (en) * | 1986-05-10 | 1989-08-01 | Toyo Seikan Kaisha, Ltd. | Methods and compositions for controlling the pear leaf blister moth, Leucoptera scitella |
US20010021378A1 (en) * | 1996-05-09 | 2001-09-13 | Dieter Hofer | Pesticide |
Non-Patent Citations (4)
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7886831B2 (en) | 2003-01-22 | 2011-02-15 | Enventure Global Technology, L.L.C. | Apparatus for radially expanding and plastically deforming a tubular member |
US7712522B2 (en) | 2003-09-05 | 2010-05-11 | Enventure Global Technology, Llc | Expansion cone and system |
US7819185B2 (en) | 2004-08-13 | 2010-10-26 | Enventure Global Technology, Llc | Expandable tubular |
FR2969463A1 (en) * | 2010-12-23 | 2012-06-29 | Solvay | Parasiticide combination, useful to control the development of parasites on animals, comprises first portion containing parasiticide composition containing alkali metal bicarbonate and second portion having parasite attractive substance |
US10709135B2 (en) | 2013-07-29 | 2020-07-14 | Attillaps Holdings | Organophosphates for treating afflictions of the skin |
US11446241B2 (en) | 2013-07-29 | 2022-09-20 | Attillaps Holdings Inc. | Treatment of ophthalmological conditions with acetylcholinesterase inhibitors |
US10500183B2 (en) | 2014-06-19 | 2019-12-10 | Attillaps Holdings | Acetylcholinesterase inhibitors for treatment of dermatological conditions |
US11045442B2 (en) | 2014-06-19 | 2021-06-29 | Attillaps Holdings | Acetylcholinesterase inhibitors for treatment of dermatological conditions |
Also Published As
Publication number | Publication date |
---|---|
CA2490680C (en) | 2015-11-24 |
PT1531840E (en) | 2012-03-08 |
BR0311899A (en) | 2005-04-12 |
US20140316000A1 (en) | 2014-10-23 |
EP1531840B8 (en) | 2012-03-21 |
CA2490680A1 (en) | 2003-12-31 |
ATE543502T1 (en) | 2012-02-15 |
JP2006501173A (en) | 2006-01-12 |
US8828921B2 (en) | 2014-09-09 |
CN1671402A (en) | 2005-09-21 |
AU2003246371A1 (en) | 2004-01-06 |
MXPA04013003A (en) | 2005-09-12 |
US9844217B2 (en) | 2017-12-19 |
EP1531840B1 (en) | 2012-02-01 |
US20050137119A1 (en) | 2005-06-23 |
ES2379253T3 (en) | 2012-04-24 |
JP4783569B2 (en) | 2011-09-28 |
CN100393220C (en) | 2008-06-11 |
EP1531840A1 (en) | 2005-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9844217B2 (en) | Allomone repulsive and kairomone attractive compositions for controlling arachnids | |
Durden et al. | Fleas (siphonaptera) | |
Hagelin et al. | Bird odors and other chemical substances: a defense mechanism or overlooked mode of intraspecific communication? | |
DE69530003T2 (en) | USE OF KONIFERYLALDEHYD AND ALPHA-HEXYL CINNAMALDEHYD FOR COMBATING INSECTS AND MITES | |
Koenraadt et al. | The role of volatiles in aggregation and host-seeking of the haematophagous poultry red mite Dermanyssus gallinae (Acari: Dermanyssidae) | |
Khater et al. | Lousicidal efficacy of camphor oil, d-phenothrin, and deltamethrin against the slender pigeon louse, Columbicola columbae | |
Gay et al. | Control of Dermanyssus gallinae (De Geer 1778) and other mites with volatile organic compounds, a review | |
Williams et al. | Laboratory And Field Assessment Of Some Kairomone Blends For Host-Seeking Aedes Aegypti1 | |
Weldon et al. | Vertebrate chemical defense: secreted and topically acquired deterrents of arthropods | |
Hasnain et al. | Synergist response of the Peach fruit fly, Bactrocera zonata (Saunders) to some ammonium based proteinaceous food bait attractants | |
Zimmer et al. | Orientation behaviour of Culicoides obsoletus (Diptera: Ceratopogonidae), a relevant virus vector in northern Europe, toward host-associated odorant cues | |
Rajchard | Kairomones-important substances in interspecific communication in vertebrates: a review | |
Pinto et al. | Chapter 11: Host-seeking behaviour and its application for surveillance and control of sand flies | |
Yerbanga et al. | Neemazal® as a possible alternative control tool for malaria and African trypanosomiasis? | |
Gries | Chemical ecology | |
Sulston et al. | Combining cattle and wound-derived synthetic attractants, POC and Bezzilure B, for sampling Chrysomya bezziana in Indonesia | |
Mehlhorn et al. | Ectoparasites (Arthropods: Acari, Insecta, Crustacea) | |
Safronov et al. | Insectoacaricide Activity of Thymol Against Menoponidae and Gamasid Mites Dermanyssus gallinae | |
Tangtrakulwanich | Sensory morphology and chemical ecology of the stable fly, Stomoxys calcitrans: Host-seeking and ovipositional selection | |
PL235761B1 (en) | Composition for preventing and fighting bee diseases and the application of hemp oil for obtaining of the composition | |
Weldon | Chemical aposematism: the potential for non‐host odours in avian defence | |
Nemer et al. | Evidence of sexual attraction by pheromone in the cedar web-spinning sawfly | |
Doherty et al. | Chemical attractants of Philornis downsi [Diptera: Muscidae], an invasive parasite of birds in the Galapagos Islands | |
Garcia | Analyzing the Effect and Trends of Rodenticides on Birds of Prey | |
Busvine et al. | Parasites |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 11003530 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2490680 Country of ref document: CA Ref document number: 4016/DELNP/2004 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/013003 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003760695 Country of ref document: EP Ref document number: 2004514863 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003246371 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003817409X Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2003760695 Country of ref document: EP |